Allergan Inc AGN:NYSE (Common Stock)
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
|---|---|---|---|---|
| 187.61 | 0.06 0.03% | 0.11% | 2,426,866 | 2.9M |
Latest News Headlines for Allergan Inc
This communication does not constitute an offer to buy or solicitation of an offer to sell any securities. Allergan has filed a solicitation/recommendation statement on Schedule 14D-9, as amended, with the SEC that has been mailed to Allergan's stockholders. In addition, Allergan has filed a preliminary proxy statement with the SEC on October 6, 2014 and intends to file a definitive proxy statement. Any definitive proxy statement will be mailed to Allergan's stockholders. INVESTORS AND STOCKHOLDERS OF ALLERGAN ARE ENCOURAGED TO READ THESE AND ANY OTHER RELEVANT DOCUMENTS THAT THE COMPANY MAY FILE WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and stockholders will be able to obtain free copies of these documents as they become available and any other documents filed with the SEC by Allergan at the SEC's website at www.sec.gov. In addition, copies will also be available at no charge at the Investors section of Allergan's website at www.allergan.com. Copies of these materials may also be requested from Allergan's information agent, Innisfree M&A; Incorporated, toll-free at 877-800-5187.
IRVINE, Calif.--(BUSINESS WIRE)--October 09, 2014-- Allergan, Inc. (NYSE: AGN) today provided the following updates on earnings per share (EPS) and sales expectations based on current information.
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, October 7, 2014 /PRNewswire/ -- Today, Analysts Review released its research reports regarding Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), CVS Health Corporation (NYSE: CVS), Valeant Pharmaceuticals International, Inc. (NYSE: VRX), Allergan Inc. (NYSE: AGN) and Jazz Pharmaceuticals plc (NASDAQ: JAZZ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6968-100free.
Latest Annual and Quarterly SEC Filings
More FilingsCompany Background
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The Company's segments include specialty pharmaceuticals, which produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth and other prescription and over-the-counter skin care products; and urologic products and the medical devices segment, which produces a range of medical devices, including breast implants for augmentation, revision and reconstructive surgery and tissue expanders; obesity intervention products, and facial aesthetics products. In April 2014, TauTona Group's subsidiary Aline Aesthetics has completed the sale of its Aline hyaluronic acid (HA) thread technology to Allergan, Inc.
expand, down-facing arrow indicating expanded view of sectionOverview
collapse, right-facing arrow indicating collapsed view of sectionFundamentals
| EPS (TTM) | 6/30/2014 | 4.37 |
|---|---|
| P/E Ratio | 6/30/2014 | 43.0 |
| Market Cap | Large Cap | 55.8B |
| Shares Outstanding | 297.18M |
| Float | 296.6M |
collapse, right-facing arrow indicating collapsed view of sectionDividends
| Dividend Yield | 0.11% |
|---|---|
| Ex-Date | 8/13/2014 |
| Dividend Announcement | 7/21/2014 |
| Date of Record | 8/15/2014 |
| Payable | $0.05 - QRTR |
| Payable Date | 9/5/2014 |
Peers Information HelpAGN Allergan Inc vs. Peers
| Peers | |
|---|---|
AGN Allergan Inc | 68.90% |
Johnson & Johnson | 10.53% |
Pfizer Inc. | -4.90% |
Merck & Co., Inc. | 17.20% |
Abbott Laboratories | 8.37% |
AGN Allergan Inc | 0.11% |
Johnson & Johnson | 2.77% |
Pfizer Inc. | 3.57% |
Merck & Co., Inc. | 3.00% |
Abbott Laboratories | 2.12% |
AGN Allergan Inc | 0.03% |
Johnson & Johnson | -0.83% |
Pfizer Inc. | 0.48% |
Merck & Co., Inc. | -0.93% |
Abbott Laboratories | 0.31% |